Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.93 Analyst target: $12.25 Upside: 318.09%
Evaxion Biotech A / S, a clinical-stage artificial intelligence and immunology platform company, identifies and develops novel immunotherapies for the treatment of various cancers, bacterial diseases, and viral infections. The company is headquartered in Hoersholm, Denmark.
See the full interactive analysis & chart →Informational only — not investment advice.